| Name | Title | Contact Details |
|---|
OncoGenex is a biopharmaceutical company committed to the development and commercialization of new therapies that address treatment resistance in cancer patients. OncoGenex has a diverse oncology pipeline, with each product candidate having a distinct mechanism of action and representing a unique opportunity for cancer drug development. OncoGenex and Teva Pharmaceutical Industries Ltd. have entered a global collaboration and licensing agreement to develop and commercialize OncoGenex' lead drug candidate, custirsen. Custirsen is currently in Phase 3 clinical development as a treatment in men with metastatic castrate-resistant prostate cancer and in patients with advanced, unresectable non-small cell lung cancer. Apatorsen is in Phase 2 clinical development and OGX-225 is currently in pre-clinical development.
WorldDoc is a Las Vegas, NV-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
We provide emergency response, fall detection, activity monitoring, medication management, vitals monitoring and care traffic control for over 150,000 clients in all 50 states.
Digital Health Information Management provider for Sub-Saharan Africa.
Sunrise Healthcare Ctr is a Anaheim, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.